BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 11:24:03 AM | Browse: 73 | Download: 0
 |
Received |
|
2025-05-30 06:19 |
|
Peer-Review Started |
|
2025-05-30 06:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-06-12 07:54 |
|
Revised |
|
2025-06-25 23:08 |
|
Second Decision |
|
2025-08-15 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-08-15 08:53 |
|
Articles in Press |
|
2025-08-15 08:53 |
|
Publication Fee Transferred |
|
2025-07-15 17:03 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-17 03:16 |
|
Publish the Manuscript Online |
|
2025-09-25 11:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mohammed Ewid, Hossam Sherif, Nazmus Saquib, Ammar Mohammed Alammari, Amro Abdelaziz Mohammed Ismail, Mohammed H Alkahlot, Ziyad T Ahmed, Faisal Zain Mohammed Al-Zabidi and Nawaf Al Mutiri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohammed Ewid, MD, Department of Internal Medicine, College of Medicine, Sulaiman Al Rajhi University, Post Office Box 777, Bukaryiah 51941, Saudi Arabia. drmohammedowid@gmail.com |
| Key Words |
Albumin-bilirubin score; Direct-acting antiviral agents; Chronic hepatitis C; Liver fibrosis; Liver function |
| Core Tip |
The albumin-bilirubin score is a simple and reproducible score that showed significant improvement following direct-acting antivirals treatment in patients with chronic hepatitis C virus infection. Moreover, it predicted advanced liver fibrosis with a sensitivity of 60% and a specificity of 83% at a cut-off value of -2.38. Accordingly, it could be utilized to monitor liver function and to determine the extent of liver fibrosis among those patients. |
| Publish Date |
2025-09-25 11:24 |
| Citation |
<p>Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. <i>World J Hepatol</i> 2025; 17(9): 110049</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i9/110049.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i9.110049 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
